GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Alf Meem Yaa for Medical Supplies and Equipment Company SJSC 9527.SR · SAR

Health Care · Tadawul · 🇸🇦 Saudi Arabia

Compare

69.70

+0.07%

Close of 5 Nov 2026, in SAR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SAR, from our data supplier.

FY2025

Revenue

SAR 305.0m

FY2019FY2025

Net income

SAR 35.0m

FY2019FY2025

Free cash flow

−SAR 27.2m

FY2019FY2025

Shareholders' equity

SAR 179.2m

FY2019FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
RevenueSAR 305.0mSAR 248.4mSAR 223.3mSAR 193.2mSAR 151.4mSAR 121.6mSAR 89.9m
Gross profitSAR 128.5mSAR 100.3mSAR 98.8mSAR 90.3mSAR 69.5mSAR 55.0mSAR 41.7m
Operating incomeSAR 42.9mSAR 49.3mSAR 37.3mSAR 30.3mSAR 24.5mSAR 22.6mSAR 16.3m
Net incomeSAR 35.0mSAR 45.4mSAR 33.5mSAR 26.7mSAR 21.2mSAR 21.1mSAR 14.8m
Diluted earnings per share4.996.494.793.813.033.012.12

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Total assetsSAR 274.5mSAR 229.4mSAR 190.2mSAR 154.4mSAR 133.9mSAR 102.5mSAR 86.0m
Cash and short-term investments—SAR 24.2mSAR 43.4mSAR 23.3mSAR 28.4mSAR 14.7mSAR 7.9m
Total liabilitiesSAR 95.3mSAR 70.6mSAR 63.1mSAR 47.0mSAR 40.5mSAR 39.0mSAR 67.8m
Debt—SAR 1.6mSAR 2.6mSAR 1.1mSAR 1.5mSAR 4.8mSAR 168,236
Shareholders' equitySAR 179.2mSAR 158.8mSAR 127.2mSAR 107.3mSAR 93.4mSAR 63.5mSAR 18.2m
Shares outstanding7m7m7m7m7m7m7m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations−SAR 26.0m−SAR 3.6mSAR 36.7mSAR 8.5mSAR 20.3mSAR 11.6mSAR 11.0m
Capital spending−SAR 1.2m−SAR 348,794−SAR 1.9m−SAR 814,466−SAR 335,033−SAR 305,010−SAR 190,964
Free cash flow−SAR 27.2m−SAR 3.9mSAR 34.7mSAR 7.7mSAR 19.9mSAR 11.3mSAR 10.8m
Dividends paid−SAR 14.0m−SAR 14.0m−SAR 14.0m−SAR 12.3m−SAR 1.6m——

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024
RevenueSAR 65.1mSAR 143.5mSAR 68.1mSAR 80.7mSAR 114.5mSAR 57.3mSAR 54.7mSAR 66.9m
Gross profitSAR 23.8mSAR 58.2mSAR 29.4mSAR 35.1mSAR 42.7mSAR 21.8mSAR 23.3mSAR 29.3m
Operating incomeSAR 11.8mSAR 58.2mSAR 9.8mSAR 15.8mSAR 17.4mSAR 10.7mSAR 14.4mSAR 14.2m
Net incomeSAR 9.9mSAR 7.1mSAR 8.3mSAR 14.0mSAR 18.8mSAR 9.4mSAR 13.5mSAR 13.3m
Diluted earnings per share1.421.011.191.992.691.341.931.90
Cash from operations——−SAR 5.0m−SAR 2.0mSAR 15.0mSAR 7.0m−SAR 19.0m−SAR 9.0m
Total assetsSAR 306.3m—SAR 297.6m—SAR 229.4mSAR 229.4mSAR 201.8m—
Cash and short-term investments——SAR 48.6mSAR 24.2mSAR 24.2mSAR 24.2mSAR 9.0mSAR 43.4m
Debt——SAR 47.6m—SAR 1.1mSAR 1.1mSAR 2.0m—
Shareholders' equitySAR 192.1m—SAR 172.0mSAR 158.8mSAR 158.8mSAR 158.8mSAR 139.8mSAR 127.2m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue16.4%20.2%—
Operating income12.3%13.7%—
Net income9.5%10.7%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin41.4%43.1%43.6%—
Operating margin16.7%16.5%16.7%—
Net margin14.5%14.5%14.7%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022
Price to earnings19.019.510.59.2
Price to sales2.23.61.61.3

Dividends and splits

Per share, in the currency the company pays

Paid for 4 years. Last went ex-dividend on 30 Jun 2026.

FY2026FY2025FY2024FY2023FY2022
Paid in the year2.002.002.002.001.75

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.